Clinical Scorecard: Survey identifies specialty-based differences in CDI management
At a Glance
Category
Detail
Condition
Clostridioides difficile infection (CDI)
Key Mechanisms
Variability in adherence to clinical practice guidelines and diagnostic testing among specialties.
Target Population
Physicians managing CDI, including gastroenterologists, infectious diseases specialists, and primary care physicians.
Care Setting
Hospital or academic settings versus independent or group practices.
Key Highlights
Differences in guideline adherence among gastroenterologists, infectious diseases specialists, and primary care physicians.
Higher familiarity with CDI guidelines in hospital or academic settings.
Primary care physicians less likely to use recommended multistep algorithms for CDI testing.
Significant variation in prescribing practices for CDI treatments among specialties.
Need for standardized diagnostic and treatment algorithms emphasized.
Guideline-Based Recommendations
Diagnosis
Standardized diagnostic testing to distinguish active CDI from colonization.
Management
Adherence to guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.
Monitoring & Follow-up
Increased familiarity with donor-derived microbiome therapies and their clinical application.
Risks
Inconsistent management practices may reflect differences in local practice rather than clinical need.
Patient & Prescribing Data
Patients with CDI managed by various specialties.
Gastroenterologists and infectious diseases specialists more likely to prescribe vancomycin taper regimens and fidaxomicin compared to primary care physicians.
Clinical Best Practices
Implement standardized diagnostic and treatment algorithms for CDI.
Enhance education and training for primary care physicians regarding CDI management.
